Nonmyeloablative allogeneic hematopoietic cell transplantation by Rainer Storb

Nonmyeloablative allogeneic hematopoietic cell transplantation by Rainer Storb, and Brenda M. Sandmaier haematol Volume 101(5): 521 -530 April 30, 2016 © 2016 by Ferrata Storti Foundation

Reproduced from: Sandmaier BM, Storb R. Reduced-intensity allogeneic transplantation regimens, Chapter 21, In: Thomas’ Hematopoietic Cell Transplantation, 5 th Edition. Rainer Storb, and Brenda M. Sandmaier Haematologica 2016; 101: 521 -530 © 2016 by Ferrata Storti Foundation

Relapse rates per patient year among 1, 092 patients. 15. Rainer Storb, and Brenda M. Sandmaier Haematologica 2016; 101: 521 -530 © 2016 by Ferrata Storti Foundation

Five-year relapse mortality and overall survival of patients with advanced hematologic malignancies who were conditioned with FLU/2 Gy TBI before HLA-matched related or unrelated HCT and postgrafting immunosuppression with MMF/calcineurin inhibitor. Rainer Storb, and Brenda M. Sandmaier Haematologica 2016; 101: 521 -530 © 2016 by Ferrata Storti Foundation

Overall survival. Rainer Storb, and Brenda M. Sandmaier Haematologica 2016; 101: 521 -530 © 2016 by Ferrata Storti Foundation

Results of retrospective analyses of transplantation outcomes in patients with hematologic malignancies after reduced intensity (RIC) or nonmyeloablative (NMA) conditioning. Rainer Storb, and Brenda M. Sandmaier Haematologica 2016; 101: 521 -530 © 2016 by Ferrata Storti Foundation

Graft-versus-host disease and use of systemic steroids. Rainer Storb, and Brenda M. Sandmaier Haematologica 2016; 101: 521 -530 © 2016 by Ferrata Storti Foundation